Latest
Amgen launches $5B buyback
Amgen said Nov. 7 that it plans to buy back $5 billion of its shares as part of a push to return profit to stockholders. Shares of the Thousand Oaks-based drugmaker jumped 4.5 percent in morning trading. Moody’s Investors Service and Fitch Ratings lowered their ratings on Amgen debt after the announcement because the biotech Read More →
Read More →Latest
Venoco CEO offers to take firm private
[EDITOR’S NOTE: There’s an updated version of this story: “Venoco sued over CEO’s offer“] The CEO of oil and gas company Venoco wants to take the company private in a proposed buyback deal that would value the entire company at $734 million. Denver-based Venoco said Aug. 29 that CEO and Chairman Tim Marquez has offered Read More →
Read More →